BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37606037)

  • 21. Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma.
    Clay MR; Pinto EM; Fishbein L; Else T; Kiseljak-Vassiliades K
    J Clin Endocrinol Metab; 2022 Mar; 107(4):1159-1169. PubMed ID: 34850906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas.
    Sarkaria IS; Stojadinovic A; Talbot SG; Hoos A; Dudas ME; Brennan MF; Ghossein RA; Singh B
    Surgery; 2004 Dec; 136(6):1122-8. PubMed ID: 15657565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma.
    Xu F; Guan Y; Zhang P; Xue L; Ma Y; Gao M; Chong T; Ren BC
    BMC Endocr Disord; 2022 May; 22(1):130. PubMed ID: 35568842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry.
    Balluff B; Frese CK; Maier SK; Schöne C; Kuster B; Schmitt M; Aubele M; Höfler H; Deelder AM; Heck A; Hogendoorn PC; Morreau J; Maarten Altelaar AF; Walch A; McDonnell LA
    J Pathol; 2015 Jan; 235(1):3-13. PubMed ID: 25201776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
    Yang Z; Cheng H; Zhang Y; Zhou Y
    Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of important invasion and proliferation related genes in adrenocortical carcinoma.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Med Oncol; 2019 Jul; 36(9):73. PubMed ID: 31321566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma.
    Kumar A; Bellayr IH; Singh HS; Puri RK
    PLoS One; 2021; 16(2):e0246632. PubMed ID: 33591997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
    Bussey KJ; Demeure MJ
    Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z; Man X; Li Z; Bi J; Liu X; Li Z; Zhu Y; Zhang Z; Kong C
    Oncol Rep; 2019 Apr; 41(4):2440-2452. PubMed ID: 30816525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an immune-related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma.
    Xu C; Qin C; Jian J; Peng Y; Wang X; Chen X; Wu D; Song Y
    Immun Inflamm Dis; 2022 Sep; 10(9):e680. PubMed ID: 36039643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
    Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications.
    Sbiera I; Kircher S; Altieri B; Lenz K; Hantel C; Fassnacht M; Sbiera S; Kroiss M
    Front Endocrinol (Lausanne); 2021; 12():795116. PubMed ID: 34956100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenocortical carcinoma - towards genomics guided clinical care.
    Crona J; Beuschlein F
    Nat Rev Endocrinol; 2019 Sep; 15(9):548-560. PubMed ID: 31147626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenocortical Carcinoma Steroid Profiles:
    Muzzi JCD; Magno JM; Cardoso MA; de Moura J; Castro MAA; Figueiredo BC
    Front Endocrinol (Lausanne); 2021; 12():672319. PubMed ID: 34194394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma.
    Huang R; Guo L; Chen C; Xiang Y; Li G; Zheng J; Wu Y; Yuan X; Zhou J; Gao W; Xiang S
    PLoS One; 2023; 18(8):e0289418. PubMed ID: 37535572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
    Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
    Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomic profiling of prostate cancer by matrix assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry imaging using Matrix Coating Assisted by an Electric Field (MCAEF).
    Wang X; Han J; Hardie DB; Yang J; Pan J; Borchers CH
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):755-767. PubMed ID: 28017863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.